• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在慢性阻塞性肺疾病患者诱导痰中,表面活性剂蛋白 A 和 D 及 KL-6 的水平升高:一项连续的痰分析。

Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.

机构信息

Department of Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan.

出版信息

Respiration. 2011;82(1):10-8. doi: 10.1159/000324539. Epub 2011 Apr 7.

DOI:10.1159/000324539
PMID:21474912
Abstract

BACKGROUND

Recent clinical studies have suggested that serum surfactant protein (SP) A, SP-D and Krebs von den Lungen-6 (KL-6) are potential biomarkers for interstitial lung diseases. Serum levels of SP-A and SP-D have also been found to be elevated in chronic obstructive pulmonary disease (COPD), but their significance has not been evaluated or compared in induced sputum samples obtained directly from the airways.

OBJECTIVE

A sequential sputum analysis was conducted to assess the value of SP-A, SP-D and KL-6 levels in COPD.

METHODS

The study material consisted of induced sputum samples from 61 subjects, 28 with COPD and 33 with prolonged cough (cough lasting >3 weeks and normal spirometry). Sputum was collected in 3 fractions (3 periods of 5 min each). Sputum levels of these proteins were measured, and receiver operating characteristic curve analysis was carried out to evaluate the sensitivity, specificity and area under the curve (AUC) for each fraction.

RESULTS

The levels of SP-A, SP-D and KL-6 were higher in patients with COPD than in those with prolonged cough in each of the fractions. Sputum levels of these proteins correlated inversely with obstruction and positively with ageing, smoking history, sputum macrophages and eosinophils. Sputum fractionation had a relatively minor effect on the levels and AUC of these proteins.

CONCLUSION

Sequential sputum analysis from 3 consecutive fractions indicated a significant difference in the levels of SP-A, SP-D and KL-6 between COPD and prolonged cough. However, sputum fractionation itself had a relatively minor effect on the levels of these proteins.

摘要

背景

最近的临床研究表明,血清表面活性蛋白(SP)A、SP-D 和 Krebs von den Lungen-6(KL-6)是间质性肺疾病的潜在生物标志物。在慢性阻塞性肺疾病(COPD)中也发现血清 SP-A 和 SP-D 水平升高,但它们在直接从气道获得的诱导痰样本中的意义尚未得到评估或比较。

目的

进行了连续的痰分析,以评估 SP-A、SP-D 和 KL-6 水平在 COPD 中的价值。

方法

研究材料包括 61 名受试者的诱导痰样本,其中 28 名患有 COPD,33 名患有持续性咳嗽(咳嗽持续>3 周且肺功能正常)。痰液采集分为 3 个部分(每个部分 5 分钟)。测量这些蛋白质的痰水平,并进行接收者操作特征曲线分析,以评估每个部分的敏感性、特异性和曲线下面积(AUC)。

结果

在每个部分中,COPD 患者的 SP-A、SP-D 和 KL-6 水平均高于持续性咳嗽患者。这些蛋白质的痰水平与阻塞呈负相关,与年龄、吸烟史、痰巨噬细胞和嗜酸性粒细胞呈正相关。痰分级对这些蛋白质的水平和 AUC 影响相对较小。

结论

来自 3 个连续部分的连续痰分析表明,COPD 和持续性咳嗽之间 SP-A、SP-D 和 KL-6 的水平存在显著差异。然而,痰分级本身对这些蛋白质的水平影响相对较小。

相似文献

1
Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.在慢性阻塞性肺疾病患者诱导痰中,表面活性剂蛋白 A 和 D 及 KL-6 的水平升高:一项连续的痰分析。
Respiration. 2011;82(1):10-8. doi: 10.1159/000324539. Epub 2011 Apr 7.
2
Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.特发性间质性肺炎血清学标志物 KL-6、SP-A、SP-D、CCL2 和 CXCL13 的诊断效能评价。
Respiration. 2019;98(6):534-545. doi: 10.1159/000503689. Epub 2019 Oct 30.
3
[Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].血清KL-6和SP-D在弥漫性结缔组织病患者间质性肺疾病诊断与治疗中的临床意义
Ryumachi. 2003 Feb;43(1):19-28.
4
Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.人肺组织蛋白质组学鉴定出表面活性蛋白A作为慢性阻塞性肺疾病的一个标志物。
J Proteome Res. 2008 Dec;7(12):5125-32. doi: 10.1021/pr800423x.
5
Prognostic performance of Krebs von den Lungen-6, surfactant protein A, surfactant protein D levels in the serum and bronchoalveolar lavage fluid in chronic fibrosing interstitial pneumonia: a retrospective study.血清和支气管肺泡灌洗液中 Krebs von den Lungen-6、表面活性剂蛋白 A、表面活性剂蛋白 D 水平对慢性纤维化间质性肺炎的预后价值:一项回顾性研究。
BMC Pulm Med. 2024 Aug 22;24(1):404. doi: 10.1186/s12890-024-03224-1.
6
[Immunity tests for respiratory diseases--SP-A, SP-D, KL-6].[呼吸系统疾病的免疫检测——表面活性蛋白A、表面活性蛋白D、KL-6]
Rinsho Byori. 2007 Apr;55(4):381-7.
7
[The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].[不同肺部疾病患者血清中KL-6和SP-D的临床研究]
Rinsho Byori. 2000 Jun;48(6):554-60.
8
[Comparison of biomarkers of pulmonary tuberculosis activity --serum surfactant proteins A and D, KL-6, C-reactive protein, and erythrocyte sedimentation rate].[肺结核活动生物标志物的比较——血清表面活性蛋白A和D、KL-6、C反应蛋白及红细胞沉降率]
Kekkaku. 2014 Jul;89(7):637-42.
9
Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.表面活性蛋白D作为评估系统性硬化症患者肺纤维化血清标志物的临床意义。
Arthritis Rheum. 2001 Jun;44(6):1363-9. doi: 10.1002/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5.
10
The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.KL-6和SP-D在慢性过敏性肺炎诊断和管理中的应用价值。
Respir Med. 2015 Dec;109(12):1576-81. doi: 10.1016/j.rmed.2015.10.005. Epub 2015 Oct 16.

引用本文的文献

1
Particles in Exhaled Air (PExA): Clinical Uses and Future Implications.呼出空气中的颗粒(PExA):临床应用及未来意义
Diagnostics (Basel). 2024 May 7;14(10):972. doi: 10.3390/diagnostics14100972.
2
KL-6 levels in the connective tissue disease population: typical values and potential confounders-a retrospective, real-world study.结缔组织病患者的 KL-6 水平:典型值及潜在混杂因素——一项回顾性真实世界研究。
Front Immunol. 2023 Jun 20;14:1098602. doi: 10.3389/fimmu.2023.1098602. eCollection 2023.
3
Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study.
从美泊利珠单抗转换治疗方案至贝那利珠单抗用于老年重症嗜酸粒细胞性哮喘患者:一项回顾性观察研究。
Intern Med. 2022;61(11):1663-1671. doi: 10.2169/internalmedicine.8180-21. Epub 2022 Jun 1.
4
Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019.新型冠状病毒肺炎中肺表面活性物质相关蛋白A和纤连蛋白与肺纤维化的相关性
Clin Chim Acta. 2021 Jun;517:48-53. doi: 10.1016/j.cca.2021.02.012. Epub 2021 Feb 22.
5
The role of mucin 1 in respiratory diseases.黏蛋白 1 在呼吸疾病中的作用。
Eur Respir Rev. 2021 Feb 2;30(159). doi: 10.1183/16000617.0149-2020. Print 2021 Mar 31.
6
Clinical and molecular features of rapidly progressive chronic hypersensitivity pneumonitis.快速进展性慢性过敏性肺炎的临床及分子特征
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):48-57. doi: 10.36141/svdld.v34i1.5388. Epub 2017 Apr 28.
7
The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation.细胞表面黏蛋白 MUC1 作为感染屏障和炎症调节剂的作用。
Front Cell Infect Microbiol. 2019 Apr 24;9:117. doi: 10.3389/fcimb.2019.00117. eCollection 2019.
8
MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function.MUC1:首个具有抗炎功能的呼吸道黏蛋白。
J Clin Med. 2017 Nov 29;6(12):110. doi: 10.3390/jcm6120110.
9
Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma.痰液富含亮氨酸的α-2糖蛋白作为哮喘气道炎症的标志物
PLoS One. 2016 Sep 9;11(9):e0162672. doi: 10.1371/journal.pone.0162672. eCollection 2016.
10
Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study.慢性阻塞性肺疾病(COPD)患者呼出的内源性颗粒中表面活性蛋白A减少:一项初步研究。
PLoS One. 2015 Dec 11;10(12):e0144463. doi: 10.1371/journal.pone.0144463. eCollection 2015.